FibroBiologics Announces Successful Manufacturing of CYWC628 Drug Product to Support Upcoming Diabetic Foot Ulcer Clinical Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. IBM
6. MU
7. FDX
8. BLZE
9. DFTX
10. NKE

Go back to FibroBiologics Announces Successful Manufacturing of CYWC628 Drug Product to Support Upcoming Diabetic Foot Ulcer Clinical Trial
(NASDAQ: FBLG) Delayed: 0.75 -0.06 (7.41%)
Previous Close $0.81    52 Week High $ 
Open $0.82    52 Week Low $ 
Day High $0.84    P/E N/A 
Day Low $0.75    EPS $ 
Volume 247,192